Creation of the Cohort of COVID19 patients and samples associated with the Biobank of the Instituto de Investigación Sanitaria Galicia Sur (IISGS)

  • Funded by National Institute of Health Carlos III [El Instituto de Salud Carlos III] (ISCIII)
  • Total publications:0 publications

Grant number: COV20_00698

Grant search

Key facts

  • Disease

    COVID-19
  • Funder

    National Institute of Health Carlos III [El Instituto de Salud Carlos III] (ISCIII)
  • Principal Investigator

    EVA POVEDA LÓPEZ
  • Research Location

    Spain
  • Lead Research Institution

    FUNDACIÓN BIOMÉDICA GALICIA SUR
  • Research Priority Alignment

    N/A
  • Research Category

    Epidemiological studies

  • Research Subcategory

    N/A

  • Special Interest Tags

    Data Management and Data Sharing

  • Study Type

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

The creation of the cohort of COVID19 patients and samples associated with the IISGS Biobank in the health area of Vigo is the basis for the study of the COVID19 disease in a standardized and quality way. It will allow the execution of clinical and experimental studies to increase our knowledge and optimize the prevention, diagnosis, clinical follow-up and treatment of patients infected by SARS-COV-2 at a local and global level, favoring consortia and study groups with other national centers and international organizations for the development of joint research projects. To this end, a Coordination Unit of the COVID19-IISGS Cohort and a Scientific-Technical Committee have been created for the evaluation of research projects that require the use of data and samples from the cohort once they have the approval of the Relevant Ethics Committees.